Femasys Operating Margin from 2010 to 2024
| FEMY Stock | USD 1.04 0.02 1.89% |
Check Femasys financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Femasys' main balance sheet or income statement drivers, such as Tax Provision of 4.3 K, Net Interest Income of 181.2 K or Interest Income of 196.4 K, as well as many indicators such as Price To Sales Ratio of 13.29, Dividend Yield of 0.0 or PTB Ratio of 0.86. Femasys financial statements analysis is a perfect complement when working with Femasys Valuation or Volatility modules.
Femasys | Operating Margin |
Latest Femasys' Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of Femasys over the last few years. It is Femasys' Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Femasys' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (20.24) % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
Femasys Operating Margin Regression Statistics
| Arithmetic Mean | (11.76) | |
| Coefficient Of Variation | (18.67) | |
| Mean Deviation | 1.59 | |
| Median | (12.53) | |
| Standard Deviation | 2.19 | |
| Sample Variance | 4.82 | |
| Range | 7.5301 | |
| R-Value | 0.26 | |
| Mean Square Error | 4.83 | |
| R-Squared | 0.07 | |
| Significance | 0.34 | |
| Slope | 0.13 | |
| Total Sum of Squares | 67.44 |
Femasys Operating Margin History
About Femasys Financial Statements
Femasys investors use historical fundamental indicators, such as Femasys' Operating Margin, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Femasys. Please read more on our technical analysis and fundamental analysis pages.
Femasys Inc., a biomedical company, focuses on womens healthcare market in the United States. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia. Femasys operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 27 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Femasys Stock Analysis
When running Femasys' price analysis, check to measure Femasys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Femasys is operating at the current time. Most of Femasys' value examination focuses on studying past and present price action to predict the probability of Femasys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Femasys' price. Additionally, you may evaluate how the addition of Femasys to your portfolios can decrease your overall portfolio volatility.